Selective HDAC inhibition for the disruption of latent HIV-1 infection.

Selective HDAC inhibition for the disruption of latent HIV-1 infection.

Item
http://www.wikidata.org/entity/Q35227888
How to Define the Latent Reservoir: Tools of the TradeEpigenetic control of HIV-1 post integration latency: implications for therapyManipulation of the host protein acetylation network by human immunodeficiency virus type 1Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsExercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrateSpecific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivoSmall Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency ReversalSecond European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, SpainGene-expression reversal of lncRNAs and associated mRNAs expression in active vs latent HIV infection.HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages.Instability of 8E5 calibration standard revealed by digital PCR risks inaccurate quantification of HIV DNA in clinical samples by qPCR.Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation.Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay.HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.Histone H3K14 hypoacetylation and H3K27 hypermethylation along with HDAC1 up-regulation and KDM6B down-regulation are associated with active pulmonary tuberculosis diseaseThe potential role for romidepsin as a component in early HIV-1 curative efforts.HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals
P2860

Selective HDAC inhibition for the disruption of latent HIV-1 infection.

Item
http://www.wikidata.org/entity/Q35227888
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Selective HDAC inhibition for the disruption of latent HIV-1 infection.
@ast
Selective HDAC inhibition for the disruption of latent HIV-1 infection.
@en
type
label
Selective HDAC inhibition for the disruption of latent HIV-1 infection.
@ast
Selective HDAC inhibition for the disruption of latent HIV-1 infection.
@en
prefLabel
Selective HDAC inhibition for the disruption of latent HIV-1 infection.
@ast
Selective HDAC inhibition for the disruption of latent HIV-1 infection.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Selective HDAC inhibition for the disruption of latent HIV-1 infection.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0102684
P407
P433
P478
P577
P5875
P698
P932